The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females-Reference-Cited by-同舟云学术

The molecular significance of methylated BRCA1 promoter in white blood cells of cancer-free females

Published:2014-11-17 Issue:1 Volume:14 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Al-Moghrabi Nisreen,Nofel Asmaa,Al-Yousef Nujoud,Madkhali Safia,Bin Amer Suad M,Alaiya Ayodele,Shinwari Zakia,Al-Tweigeri Taher,Karakas Bedri,Tulbah Asma,Aboussekhra Abdelilah

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-14-830.pdf

Reference43 articles.

1. Wolffe AP, Matzke MA: Epigenetics: regulation through repression. Science. 1999, 286: 481-486. 10.1126/science.286.5439.481.

2. Cropley JE, Martin DI, Suter CM: Germline epimutation in humans. Pharmacogenomics. 2008, 9 (12): 1861-1868. 10.2217/14622416.9.12.1861.

3. Jones PA, Baylin SB: The fundamental role of epigenetic events in cancer. Nat Rev. 2002, 3 (6): 415-428.

4. Chong S, Youngson NA, Whitelaw E: Heritable germline epimutation is not the same as transgenerational epigenetic inheritance. Nat Genet. 2007, 39 (5): 574-575. 10.1038/ng0507-574. author reply 575–576

5. Horsthemke B: Heritable germline epimutations in humans. Nat Genet. 2007, 39 (5): 573-574. author reply 575–576

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women;International Journal of Molecular Sciences;2024-03-07

2. BRCA1 methylation in breast duct carcinoma, a practical study in Duhok-Iraq;Cellular and Molecular Biology;2023-12-20

3. Contribution of constitutional BRCA1 promoter methylation to early-onset and familial breast cancer patients from Pakistan;Breast Cancer Research and Treatment;2023-08-01

4. Buffy coat signatures of breast cancer risk in a prospective cohort study;Clinical Epigenetics;2023-06-12

5. MicroRNA-155-5p, Reduced by Curcumin-Re-Expressed Hypermethylated BRCA1, Is a Molecular Biomarker for Cancer Risk in BRCA1-methylation Carriers;International Journal of Molecular Sciences;2023-05-19